ACHE and Alzheimer disease: Additionally, inhibiting AD-related phosphodiesterases (PDEs) could consequently enhance synaptic transmission and mitigating cognitive deficiencies.538,539 Compound 50 is a dual-inhibitor of AChE and PDE4D.